StockNews.com Upgrades Cumberland Pharmaceuticals (NASDAQ:CPIX) to Strong-Buy

StockNews.com upgraded shares of Cumberland Pharmaceuticals (NASDAQ:CPIX) from a buy rating to a strong-buy rating in a research report report published on Thursday.

Cumberland Pharmaceuticals Price Performance

Shares of NASDAQ:CPIX opened at $4.70 on Thursday. The stock’s fifty day simple moving average is $4.72 and its two-hundred day simple moving average is $3.31. The stock has a market cap of $65.65 million, a PE ratio of -6.10 and a beta of -0.35. The company has a current ratio of 1.13, a quick ratio of 0.99 and a debt-to-equity ratio of 0.41. Cumberland Pharmaceuticals has a 1-year low of $1.04 and a 1-year high of $7.25.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last announced its earnings results on Tuesday, May 6th. The specialty pharmaceutical company reported $0.15 earnings per share for the quarter. Cumberland Pharmaceuticals had a negative return on equity of 9.50% and a negative net margin of 29.54%.

Hedge Funds Weigh In On Cumberland Pharmaceuticals

A hedge fund recently raised its stake in Cumberland Pharmaceuticals stock. Two Sigma Investments LP boosted its stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) by 94.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 37,649 shares of the specialty pharmaceutical company’s stock after acquiring an additional 18,271 shares during the period. Two Sigma Investments LP owned 0.27% of Cumberland Pharmaceuticals worth $89,000 as of its most recent filing with the SEC. 15.51% of the stock is currently owned by institutional investors and hedge funds.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.